Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data

Picket, AndyToxin Science Limited, Wrexham, UK; Botulinum research Center, UMASS Dartmouth, MA, USAModern clinical use of botulinum toxin (BoNT) by doctors requires evidence- based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, spe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Pickett A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/4f46c94a934842248ae15ea23865ba92
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4f46c94a934842248ae15ea23865ba92
record_format	dspace
spelling	oai:doaj.org-article:4f46c94a934842248ae15ea23865ba922021-12-02T00:30:22ZEvaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data1177-54671177-5483https://doaj.org/article/4f46c94a934842248ae15ea23865ba922011-09-01T00:00:00Zhttp://www.dovepress.com/evaluating-botulinum-toxin-products-for-clinical-use-requires-accurate-a8256https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Picket, AndyToxin Science Limited, Wrexham, UK; Botulinum research Center, UMASS Dartmouth, MA, USAModern clinical use of botulinum toxin (BoNT) by doctors requires evidence- based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, speculative statements have been used and repeated until injectors have come to believe they are solid facts.1 Yet no supporting data exist. Consequently, doctors have often been reluctant to change to or even try other products because of what they have been told. This has not been a good situation for either clinicians or patients. We have published about these &quot;urban legends&quot;1 and tried, on many occasions, to correct these inaccuracies (see, for example,2,3).&nbsp;Pickett ADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1287-1290 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Pickett A Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
description	Picket, AndyToxin Science Limited, Wrexham, UK; Botulinum research Center, UMASS Dartmouth, MA, USAModern clinical use of botulinum toxin (BoNT) by doctors requires evidence- based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, speculative statements have been used and repeated until injectors have come to believe they are solid facts.1 Yet no supporting data exist. Consequently, doctors have often been reluctant to change to or even try other products because of what they have been told. This has not been a good situation for either clinicians or patients. We have published about these &quot;urban legends&quot;1 and tried, on many occasions, to correct these inaccuracies (see, for example,2,3).&nbsp;
format	article
author	Pickett A
author_facet	Pickett A
author_sort	Pickett A
title	Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
title_short	Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
title_full	Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
title_fullStr	Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
title_full_unstemmed	Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
title_sort	evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/4f46c94a934842248ae15ea23865ba92
work_keys_str_mv	AT picketta evaluatingbotulinumtoxinproductsforclinicaluserequiresaccuratecompleteandunbiaseddata
_version_	1718403674138476544

Evaluating botulinum toxin products for clinical use requires accurate, complete, and unbiased data

Ejemplares similares